Discovering Drugs
with Deep Physics and AI

We are an in silico drug discovery company relying on unique quantum-inspired algorithms that predict affinity combined with AI to rapidly discover more innovative molecules with better chances of success.

Our science

We are a spin-off of the École normale supérieure - PSL, focused on in silico drug discovery. We combine AI and disruptive structure-based affinity algorithms, which are both accurate and 10,000x faster than competition, to generate lead-like molecules for a given target.

Find out more


We collaborate with innovative R&D pharmaceutical companies, biotechs & CROs and seek to build our own portfolio with dozens of internal projects. We focus on identifying or generating molecules of interest for a given project and do not sell our technology as software.

discover our projects


Keep up with the latest news, updates and announcements from the Aqemia team.

See all news

About us

We are a team of passionate people at the crossroads of theoretical physics, medicinal chemistry and artificial intelligence.

Learn more


We are seeking highly skilled, motivated and curious individuals to develop our unique science to discover new therapeutic molecules!

join us

Sign up to receive our news

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.